BPC-157 Telehealth Evaluation
Physician-guided evaluation for BPC-157–based peptide therapy when clinically appropriate.
$99 Consultation | $300 Total If Approved
Understanding BPC-157
BPC-157 is a synthetic peptide derived from a naturally occurring protein fragment studied in preclinical research.
BPC-157 is not FDA-approved for the diagnosis, treatment, cure, or prevention of disease.
Through telehealth, licensed providers evaluate whether BPC-157–based therapy may be clinically appropriate based on individual medical history and goals.
Who Typically Explores BPC-157 Telehealth?
- Maintain active training routines
- Experience slower recovery following physical activity
- Prefer physician-guided oversight
- Seek structured and regulated access
- Want pharmacy fulfillment rather than self-sourcing
Appropriateness is determined only after medical consultation.
How It Works
You’ll begin with a brief virtual consultation with a licensed medical provider, who will review your medical history and determine whether this therapy may be appropriate for you.
If treatment is recommended, your prescription is sent to a licensed U.S. compounding pharmacy and shipped directly to your home, typically within 3–7 business days.
Consultation Cost
The total cost is $300, which includes:
If a peptide therapy is not clinically appropriate, there is no charge for the visit.
- All therapies are prescribed only when clinically appropriate and based on physician evaluation.
Medical & Regulatory Considerations
BPC-157–based therapies offered through telehealth may involve compounded formulations.
- Are not FDA-approved
- May have limited long-term human safety data
- Are prescribed only under physician supervision
BPC-157 is considered investigational in certain contexts.
All prescribing decisions are based on individualized clinical evaluation.
The FDA has not evaluated statements on this website.
Individual results vary.
Frequently Asked Questions
No therapy is guaranteed to treat or heal injuries. BPC-157 is studied for its role in cellular signaling pathways and is prescribed only when clinically appropriate.
Compounded peptide therapy is legal when prescribed by a licensed provider and fulfilled by a licensed pharmacy in compliance with applicable regulations.
BPC-157 is not FDA-approved for the diagnosis, treatment, cure, or prevention of disease.
Additional peptides may be considered after the first month when clinically indicated and reviewed by your provider.
Interested in Structured Recovery Support?
Schedule your $99 physician consultation to determine clinical appropriateness.